Antares Pharma Statistics Share Statistics Antares Pharma has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.78M, so 0% of the outstanding
shares have been sold short.
Short Interest 4.78M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.25
Valuation Ratios The PE ratio is 13.12 and the forward
PE ratio is null.
Antares Pharma's PEG ratio is
-0.72.
PE Ratio 13.12 Forward PE n/a PS Ratio 3.3 Forward PS n/a PB Ratio 3.46 P/FCF Ratio 20.25 PEG Ratio -0.72
Financial Ratio History Enterprise Valuation Antares Pharma has an Enterprise Value (EV) of 565.49M.
EV / Sales 3.07 EV / EBITDA 8.55 EV / EBIT 15.44 EV / FCF 18.85
Financial Position The company has a current ratio of 2.74,
with a Debt / Equity ratio of 0.14.
Current Ratio 2.74 Quick Ratio 2.55 Debt / Equity 0.14 Debt / EBITDA 0.36 Debt / FCF 0.8 Interest Coverage 0
Financial Efficiency Return on Equity is 26.34% and Return on Invested Capital is 25.02%.
Return on Equity 26.34% Return on Assets 17.98% Return on Invested Capital 25.02% Revenue Per Employee $915.33K Profits Per Employee $230.29K Employee Count 201 Asset Turnover 0.71 Inventory Turnover 5.91
Taxes Income Tax 15.98M Effective Tax Rate 25.67%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.15, so Antares Pharma's
price volatility has been higher than the market average.
Beta 1.15 52-Week Price Change n/a 50-Day Moving Average 4.86 200-Day Moving Average n/a Relative Strength Index (RSI) 78.69 Average Volume (20 Days) 5,230,217
Income Statement In the last 12 months, Antares Pharma had revenue of 183.98M
and earned 46.29M
in profits. Earnings per share was 0.27.
Revenue 183.98M Gross Profit 115.7M Operating Income 62.27M Net Income 46.29M EBITDA 66.17M EBIT 62.27M Earnings Per Share (EPS) 0.27
Full Income Statement Balance Sheet The company has 65.91M in cash and 23.95M in
debt, giving a net cash position of 41.96M.
Cash & Cash Equivalents 65.91M Total Debt 23.95M Net Cash 41.96M Retained Earnings -176.34M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 36.62M
and capital expenditures -6.62M, giving a free cash flow of 30M.
Operating Cash Flow 36.62M Capital Expenditures -6.62M Free Cash Flow 30M FCF Per Share 0.18
Full Cash Flow Statement Margins Gross margin is 62.89%, with operating and profit margins of 33.85% and 25.16%.
Gross Margin 62.89% Operating Margin 33.85% Pretax Margin 33.85% Profit Margin 25.16% EBITDA Margin 35.97% EBIT Margin 33.85% FCF Margin 16.31%
Dividends & Yields ATRS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 7.62% FCF Yield 4.94%
Dividend Details Analyst Forecast Currently there are no analyst rating for ATRS.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 2.51 Graham Upside -55.1%
Stock Splits The last stock split was on Jan 29, 1999. It was a
backward
split with a ratio of 1:5.
Last Split Date Jan 29, 1999 Split Type backward Split Ratio 1:5
Scores Altman Z-Score n/a Piotroski F-Score n/a
